These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 31680423)
1. Using spatial tracking with magnetic resonance imaging/ultrasound-guided biopsy to identify unilateral prostate cancer. Zhou SR; Priester AM; Jayadevan R; Johnson DC; Yang JJ; Ballon J; Natarajan S; Marks LS BJU Int; 2020 Mar; 125(3):399-406. PubMed ID: 31680423 [TBL] [Abstract][Full Text] [Related]
2. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy. Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973 [TBL] [Abstract][Full Text] [Related]
4. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Johnson DC; Yang JJ; Kwan L; Barsa DE; Mirak SA; Pooli A; Sadun T; Jayadevan R; Zhou S; Priester AM; Natarajan S; Bajgiran AM; Shakeri S; Sisk A; Felker ER; Raman SS; Marks LS; Reiter RE Cancer; 2019 Sep; 125(17):2955-2964. PubMed ID: 31042322 [TBL] [Abstract][Full Text] [Related]
5. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer. Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783 [TBL] [Abstract][Full Text] [Related]
6. The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy. Raskolnikov D; George AK; Rais-Bahrami S; Turkbey B; Siddiqui MM; Shakir NA; Okoro C; Rothwax JT; Walton-Diaz A; Sankineni S; Su D; Stamatakis L; Merino MJ; Choyke PL; Wood BJ; Pinto PA J Urol; 2015 Jul; 194(1):105-111. PubMed ID: 25623751 [TBL] [Abstract][Full Text] [Related]
7. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer. Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182 [TBL] [Abstract][Full Text] [Related]
8. Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience. Kim JJ; Kim T; Lee H; Byun SS; Lee SE; Choe G; Hong SK PLoS One; 2018; 13(8):e0202872. PubMed ID: 30157232 [TBL] [Abstract][Full Text] [Related]
10. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694 [TBL] [Abstract][Full Text] [Related]
11. Biopsy-Integrated 3D Magnetic Resonance Imaging Modeling of Prostate Cancer and Its Application for Gleason Grade and Tumor Laterality Assessment. Kim J; Lim B; Jeong IG; Ro JY; Go H; Cho YM; Park KJ Arch Pathol Lab Med; 2023 Feb; 147(2):159-166. PubMed ID: 35512234 [TBL] [Abstract][Full Text] [Related]
12. Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance. Dieffenbacher S; Nyarangi-Dix J; Giganti F; Bonekamp D; Kesch C; Müller-Wolf MB; Schütz V; Gasch C; Hatiboglu G; Hauffe M; Stenzinger A; Duensing S; Schlemmer HP; Moore CM; Hohenfellner M; Radtke JP Eur Urol Focus; 2021 Jan; 7(1):102-110. PubMed ID: 30878348 [TBL] [Abstract][Full Text] [Related]
13. Pathological Findings in Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy: Relation to Prostate Cancer Focal Therapy. Gordetsky J; Rais-Bahrami S; Epstein JI Urology; 2017 Jul; 105():18-23. PubMed ID: 28238758 [TBL] [Abstract][Full Text] [Related]
14. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit. Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844 [TBL] [Abstract][Full Text] [Related]
15. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study. van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer. Demirtaş A; Sönmez G; Tombul ŞT; Demirtaş T; Akgün H Urol Int; 2019; 103(3):256-261. PubMed ID: 31242496 [TBL] [Abstract][Full Text] [Related]
17. Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer. Zhou Z; Zhou Y; Yan W; Sun H; Li Q; Li H; Ji Z Urol Oncol; 2021 Oct; 39(10):730.e17-730.e22. PubMed ID: 34175215 [TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy. Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437 [TBL] [Abstract][Full Text] [Related]
19. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824 [TBL] [Abstract][Full Text] [Related]
20. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens. Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]